Thursday, August 31, 2017 10:15 PM ET
Continued Level of Significant Insider Selling at Celgene (CELG)
There was a substantial sale of shares of Celgene by an insider today, as indicated in a form 4 document filed with the SEC. One insider — Dr Ernest Mario, Director — disposed of 12,000 shares in the company having a market value of approximately $1,454,880. There have been 2 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 26,006 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 38,006 shares and have averaged 12,669 shares per transaction over this time period.
The number of insider buy/sell trades at Celgene is above that of the 265 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 321 buy/sell trades during this period for an average of 1.2 transactions per company. However, the number of shares traded per transaction by Celgene insiders is lower than its peers. Within the peer group there were 7,744,034 shares purchased and 14,501,844 shares sold with company insiders disposing of 21,052 shares on average over this time period.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data used in composing and writing this story.
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.